Literature DB >> 15276120

Time trends in warfarin-associated hemorrhage.

Nils Kucher1, Luis R Castellanos, Rene Quiroz, Sophia Koo, John Fanikos, Samuel Z Goldhaber.   

Abstract

The annual incidence of warfarin-related bleeding at Brigham and Women's Hospital increased from 0.97/1,000 patient admissions in the first time period (January 1995 to October 1998) to 1.19/1,000 patient admissions in the second time period (November 1998 to August 2002) of this study. The proportion of patients with major and intracranial bleeding increased from 20.2% and 1.9%, respectively, in the first time period, to 33.3% and 7.8%, respectively, in the second.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276120     DOI: 10.1016/j.amjcard.2004.04.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Retroperitoneal hemorrhagic shock in a patient on warfarin therapy.

Authors:  Sankar Subramanian; Subramanian Marappa Gounder; Arunkumar Thirunarayanan; Anand Kannan; Nandigam Venu
Journal:  J Emerg Trauma Shock       Date:  2009-05

2.  Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients.

Authors:  Gregory Piazza; Erin J Rosenbaum; William Pendergast; Joseph O Jacobson; Robert C Pendleton; Gordon D McLaren; C Gregory Elliott; Scott M Stevens; William F Patton; Ousama Dabbagh; Marilyn D Paterno; Elaine Catapane; Zhongzhen Li; Samuel Z Goldhaber
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

3.  Experimental model of warfarin-associated intracerebral hemorrhage.

Authors:  Christian Foerch; Ken Arai; Guang Jin; Kyung-Pil Park; Stefanie Pallast; Klaus van Leyen; Eng H Lo
Journal:  Stroke       Date:  2008-09-04       Impact factor: 7.914

Review 4.  Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio?

Authors:  Geno J Merli; George Tzanis
Journal:  J Thromb Thrombolysis       Date:  2008-04-05       Impact factor: 2.300

5.  Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk.

Authors:  Andreas Charidimou; Clare Shakeshaft; David J Werring
Journal:  Front Neurol       Date:  2012-09-19       Impact factor: 4.003

6.  Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation - a nationwide cohort study.

Authors:  Marie Jakobsen; Christophe Kolodziejczyk; Eskild Klausen Fredslund; Peter Bo Poulsen; Lars Dybro; Søren Paaske Johnsen
Journal:  BMC Health Serv Res       Date:  2017-06-12       Impact factor: 2.655

7.  Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol.

Authors:  Vincent D Pellegrini; John William Eikelboom; C McCollister Evarts; Patricia D Franklin; Kevin L Garvin; Samuel Z Goldhaber; Richard Iorio; Carol Ann Lambourne; Jay Magaziner; Laurence Magder
Journal:  BMJ Open       Date:  2022-03-08       Impact factor: 2.692

8.  The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.

Authors:  Fangzhe Chen; Weifeng Wang; Hongyan Ding; Qi Yang; Qiang Dong; Mei Cui
Journal:  J Neuroinflammation       Date:  2016-08-26       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.